Current Opinion in Infectious Diseases

Article	Citations
Corticosteroids for viral central nervous system infections	43
Complexities of cardiomyopathy in septic shock	39
From diagnosis to management: current perspectives on congenital cytomegalovirus infection	38
La Crosse virus encephalitis in children	34
Potential opportunities and challenges for infection prevention and control for cystic fibrosis in the modern era	34
Postexposure prophylaxis for occupational exposure to selected pathogens for healthcare personnel	31
Hematopoietic stem cell transplantation and cellular therapy in persons living with HIV	29
Editorial introductions	29
Skin and soft tissue infections in the elderly	27
Strongyloidiasis-related lung involvement: too much of a bad thing	27
Invasive aspergillosis in coronavirus disease 2019: a practical approach for clinicians	25
Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside	25
Surgical management of cystic echinococcosis of the liver	25
Fusarium species central nervous system infection	25
Epstein–Barr virus posttransplant lymphoproliferative disorder: update on management and outcomes	25
Bacterial cholesterol-dependent cytolysins and their interaction with the human immune response	25
New therapies for nontuberculous mycobacterial lung infection	24
Babesiosis in immunosuppressed hosts: pathogenesis, diagnosis and management	23
Progress and challenges in human papillomavirus and cervical cancer in southern Africa	23
Typhoid fever control in the 21st century: where are we now?	22
Immunocompromised host section: Adoptive T-cell therapy for dsDNA viruses in allogeneic hematopoietic cell transplant recipients	22
Mycobacterial skin infection	21
Methicillin-resistant Staphylococcus aureus lung infection in coronavirus disease 2019: how common?	21
Tuberculosis molecular bacterial load assay in the management of tuberculosis	20
Viral meningitis and encephalitis: an update	20

Tick-borne encephalitis	19
Resistant herpes simplex virus infections – who, when, and what's new?	19
Malaria in pregnancy: baby steps	19
Mitigation of nontuberculous mycobacteria in hospital water: challenges for infection prevention	19
Mpox in people living with HIV	19
Follow-up blood culture in Gram-negative bacilli bacteraemia: for whom is follow-up blood culture useful?	19
Does climate change threaten delivery of HIV care in resource-limited settings?	17
Management of neonates born to mothers with active genital herpes simplex virus infection: an alternative approach	17
The reemergence of Streptococcus pyogenes in skin and soft tissue infections: a review of epidemiology, pathogenesis, and management strategies	17
Appropriate surgical management in skin and soft tissue infections	17
New diagnostic strategies to distinguish Crohn's disease and gastrointestinal tuberculosis	16
Diagnostic stewardship: what impacts antibiotics use?	16
Diagnostic approach and update on encephalitis	16
Editorial introductions	16
Gut microbiome and its clinical implications: exploring the key players in human health	16
CMV antiviral stewardship in transplantation – the next frontier	15
Using antibiotics wisely	15
How to differentiate skin rash in covid, mononucleosis, chickenpox, sixth disease and measles	15
Large lessons learned from small vessels: coronary microvascular dysfunction in HIV	15
Immunotherapeutic approaches to HIV cure and remission	14
Update on the treatment of chronic pulmonary aspergillosis	14
Prenatal and postnatal antiviral therapies for the prevention and treatment of congenital cytomegalovirus infections	14
Risk stratification for selecting empiric antibiotherapy during and after COVID-19	13
Drivers of melioidosis endemicity: epidemiological transition, zoonosis, and climate change	13
The microbiota in respiratory tract infections: from association to intervention	13
The impact of coronavirus disease 2019 on people with HIV	13
Respiratory syncytial virus in children: epidemiology and clinical impact post-COVID-19	12
Human adenovirus lung disease: outbreaks, models of immune-response-driven acute lung injury and pandemic potential	12
Respiratory syncytial virus prevention in immunocompromised hosts: gaps and opportunities	12
Editorial introductions	12
Beyond antivirals: virus-specific T-cell immunotherapy for BK virus haemorrhagic cystitis and JC virus progressive multifocal leukoencephalopathy	12
The plumbing problem: rising antimicrobial resistance in building water systems	12
The role of macrolides in severe community-acquired pneumonia and the potential impact of macrolide-resistant Mycoplamsa pneumoniae	12
Short treatment duration for community-acquired pneumonia	11
H5 and H9 avian influenza – potential re-emergent zoonotic threats to humans	11
New trends in congenital syphilis: epidemiology, testing in pregnancy, and management	11
Emerging treatment options for skin and soft tissue infections tailoring drug selection to individual patients	11
Respiratory metagenomics: route to routine service	11
Update on drug treatments for multidrug resistant tuberculosis	11
Editorial: Pathogenesis and immune response – editorial	11
An overview of risk factors, management and prevention of cochlear implant infections	11
The microbiome as a biomarker of anal precancerous lesions in people with HIV	11
Childhood tuberculosis	11
Interpreting and managing preservation fluids positive for Gram-negative bacteria	11
The disease burden of respiratory syncytial virus in Infants	10
Data science for pediatric infectious disease: utilizing COVID-19 as a model	10
A new era of HIV care for age-associated multimorbidity	10
Emerging infections in vulnerable hosts: Stenotrophomonas maltophilia and Elizabethkingia anophelis	10
Travellers’ diarrhoea – solidifying our knowledgebase	10
Urinary tract infections in immunocompromised patients	10

Antibiotic therapy for nonfermenting Gram-negative bacilli infections: future perspectives	10
Short-course antibiotic strategies for ventilator-associated pneumonia	10
Novel techniques in the treatment of skin and soft tissue infection	9
Genome-wide approaches to bacterial strain typing: a history and review of recent methodological advances	9
Pneumocystis jirovecii in solid organ transplant recipients: updates in epidemiology, diagnosis, treatment, and prevention	9
Neurobrucellosis	9
Identifying patients with difficult-to-treat acute bacterial skin infections	9
Latent tuberculosis screening and treatment in solid organ and hematopoietic stem cell transplant candidates and recipients	9
The role of Gram-negative bacteria in skin and soft tissue infections	9
Endemic, epidemic and pandemic infections: the roles of natural and acquired herd immunity	9
Skin and soft tissue infections in solid organ transplants	9
Burden of influenza in the elderly: a narrative review	9
Editorial introductions	9
Updates on the neurological manifestations of SARS-CoV-2 infection	9
Immune responses and severe dengue: what have we learned?	8
Therapeutic agents for the treatment of human mpox	8
Duration of antibiotic therapy in Gram-negative infections with a particular focus on multidrug-resistant pathogens	8
Editorial introductions	8
Surgical site infection prophylaxis: what have we learned and are we making progress?	8
Policy and planning for large epidemics and pandemics – challenges and lessons learned from COVID-19	8
Chagas disease in the immunocompromised host	8
Antibiotic treatment of acute bacterial skin and skin structure infections	8
Effective strategies for managing trimethoprim-sulfamethoxazole and levofloxacin-resistant Stenotrophomonas maltophilia infections: bridging the gap between scientific evidence and clinical practice	8
Endemic viral infections in immunocompromised hosts: Dengue, Chikungunya, Zika	8
The implications of the COVID-19 pandemic for long term care facilities	8
New evidence for managing Gram-negative bloodstream infections	8
The evolution of knowledge for treating Gram-negative bacterial infections	8
The role of older antibiotics in the treatment of skin and soft tissue infections: current perspectives	8
Dose optimisation of antibiotics used for meningitis	8
Mycetoma, chromoblastomycosis and other deep fungal infections: diagnostic and treatment approach	8
Preventing respiratory viral transmission in healthcare settings	8
Universal versus targeted treatment of neonatal herpes simplex virus among neonates presenting for sepsis evaluations	7
Editorial introductions	7
Editorial introductions	7
Management of nonfermenting gram-negative infections: a critique of the guidelines	7
Editorial introductions	7
Chimeric antigen receptor-T-cell therapies going viral: latent and incidental viral infections	7
Cytomegalovirus in primary immunodeficiency	7
Community-acquired skin and soft-tissue infections in people who inject drugs	7
Medical management of cystic echinococcosis	7
When is it a sexually transmitted infection? Intimate contact transmission of pathogens not traditionally defined as STIs	7
Editorial introductions	7
Editorial: Friends and foes: “The quarrels of friends are the opportunities of foes”	7
Choosing antibiotic therapy for severe community-acquired pneumonia	6
Editorial introductions	6
Climate change and resilience for antimicrobial stewardship and infection prevention	6
Empirical antibiotic therapy for difficult-to-treat Gram-negative infections: when, how, and how long?	6
Risk factors for cognitive decline in persons with HIV	6
Novel strategies for prevention and treatment of antimicrobial resistance in sexually-transmitted infections	6
Horizontal versus vertical strategies for infection prevention: current practices and controversies	6
Shifting the power: scale-up of access to point-of-care and self-testing for sexually transmitted infections in low-income and middle-income settings	6
Antiviral therapies for influenza	6
The power of story: what Victorian novels can teach us about public health	6
Giardia and growth impairment in children in high-prevalence settings: consequence or co-incidence?	6
Biomarkers to predict cardiovascular disease in people living with HIV	6
Viral infections and inborn errors of immunity	5
Viral diarrheas – newer advances in diagnosis and management	5
Editorial introductions	5
How to use new antibiotics in the therapy of ventilator-associated pneumonia	5
Risk factors for severity in seasonal respiratory viral infections and how they guide management in hematopoietic cell transplant recipients	5
Current challenges in neurocysticercosis: recent data and where we are heading	5
Brain abscess in immunocompetent patients: recent findings	5
Current international and national guidelines for managing skin and soft tissue infections	5
Human toxoplasmosis: current advances in the field	5
Strongyloides stercoralis infection in solid organ transplant recipients	5
Antiviral combination treatment strategies for SARS-CoV-2 infection in immunocompromised patients	5
Antifungal hypersensitivity reactions and cross-reactivity patterns	5
Nontyphoidal Salmonella infections acquired from poultry	4
Vaccine hesitancy and other challenges to sexually transmitted infection vaccine acceptance	4
Lenacapavir: a first-in-class capsid inhibitor for HIV treatment and prevention	4
Editorial introductions	4
‘No cyst, no echinococcosis’: a scoping review update on the diagnosis of cystic echinococcosis after the issue of the WHO-IWGE Expert Consensus and current perspectives	4
Impact of respiratory viral infections on nasopharyngeal pneumococcal colonization dynamics in children	4
The role of sulbactam-durlobactam in treating carbapenem-resistant Acinetobacter infections	4
To proceed or delay? The dilemma of community-acquired respiratory viruses in adults and pediatrics before allogeneic stem cell transplantation and chimeric-antigen-receptor T-cell therapy	4
Dengue encephalitis: what's new?	4
Central nervous system infections in the tropics	4
What will it take to meet UNAIDS targets for preexposure prophylaxis users?	4
Editorial introductions	4
A work in progress: antimicrobial stewardship in solid organ transplant patient populations	4

Adjuvanted recombinant zoster vaccine in solid organ transplant and hematopoietic stem-cell transplant recipients	4
The microbiology and pathogenesis of nonfermenting Gram-negative infections	4
Escherichia coli 0157:H7 virulence factors and the ruminant reservoir	4
Skin and soft tissue infections due to rapidly growing mycobacteria	4
Neutropenia and antibiotics: when, what, how and why?	4
Infant feeding: emerging concepts to prevent HIV transmission	4
Advances and challenges in sexually transmitted infections prevention among men who have sex with men in Asia	4
Lenacapavir and the novel HIV-1 capsid inhibitors: an emerging therapy in the management of multidrug-resistant HIV-1 virus	3
How to treat severe Acinetobacter baumannii infections	3
Current challenges in acute bacterial skin infection management	3
Host-directed immunotherapy for viral infections	3
NSAIDs for early management of acute respiratory infections	3
Gastrointestinal involvement in post-acute Coronavirus disease (COVID)-19 syndrome	3
Left ventricular assist device-associated driveline infections as a specific form of complicated skin and soft tissue infection/acute bacterial skin and skin structure infection – issues and therapeut	3
Epidemiology of Gram-negative bacteria during coronavirus disease 2019. What is the real pandemic?	3
Endemic mycoses – are we making progress in management?	3
New antibiotics in clinical pipeline for treating infections caused by metallo-β-lactamases producing Gram-negative bacteria	3
Mpox: emergence following smallpox eradication, ongoing outbreaks and strategies for prevention	3
The present and future of blood virome in allogeneic hematopoietic cell transplant recipients	3
Hyperammonemia syndrome in immunosuppressed individuals	3
When antimicrobial stewardship begins with microbiological test requests: the case of asymptomatic bacteriuria	3
Role of new antibiotics in extended-spectrum β-lactamase-, AmpC- infections	3
Dermatological manifestations during Dengue, Chikungunya, and Zika infections	3
Mpox exposure and transmission in healthcare settings during the 2022 global outbreak	3
Infectious mononucleosis: new concepts in clinical presentation, epidemiology, and host response	3
The role of the genital microbiota in the acquisition and pathogenesis of sexually transmitted infections	3
Respiratory viral infections in children with cancer and febrile neutropenia and children undergoing hematopoietic stem cell transplantation	3